The World Health Organisation (WHO) on Wednesday advised patients with mild or moderate cases of the Coronavirus (COVID-19) against the use of antidepressant drug, fluvoxamine, and the gout drug colchicine. | Pulse Nigeria
Grant to enhance evidence-informed guideline recommendations for newborn and young child health in three sub-Saharan African countries cochrane.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cochrane.org Daily Mail and Mail on Sunday newspapers.
WHO recommends antiviral drug for patients with non-severe Covid at highest risk of hospital admission miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The antiviral drug molnupiravir is conditionally recommended for patients with non-severe covid-19 who are at highest risk of hospitalization, says a WHO Guideline Development Group of international experts in The BMJ today.